What Doctor Evidence does

Dr.Evidence (legal name Doctor Evidence, LLC) is an AI-powered labeling and regulatory landscape intelligence platform serving biopharma companies globally. Founded in 2004 by Robert Battista and headquartered in Santa Monica, California, the company combines 25+ proprietary AI models — spanning generative AI, machine learning, and natural language processing — with a curated corpus of 100+ million documents drawn from health authorities including the FDA, EMA, PMDA, Health Canada, and TGA. The platform is positioned as the first consolidated life sciences intelligence environment, with 20+ years of continuous operation in the pharma landscape intelligence space.

The platform is organized into four core product modules: Labels Intelligence (728,000+ drug labels from 11 health authorities with side-by-side comparison and competitive monitoring), Trials Intelligence (1.1 million clinical trials from WHO ICTRP), Literature Intelligence (70 million scientific citations with generative AI summarization, plus 31 million patents and 500,000 NIH grants), and Regulatory Documents Intelligence (140,000 FDA/EMA approval packages and 4,000 guidance documents with generative AI chat). A zero-IP-leakage architecture is marketed as a differentiator, with proprietary data guaranteed not to train shared models. Customers include established, emerging, and generics biopharma companies across North America, Europe, and Asia Pacific.

Revenue is generated through quote-based enterprise SaaS subscriptions sold via a direct field sales motion centered on demo booking, with white-glove search optimization and ongoing support bundled into annual contracts. The company has 51-100 employees, has raised only $1.5M in disclosed funding (in 2011), and reports an average 15-year client tenure among its top ten customers, with a self-claimed 6:1 ROI from automation. Leadership includes CEO Robert Battista (MBA, FRSPH, FRCP Edin.), co-founder/CMO Todd Feinman, co-founder/CTO Edan Shalev, Senior Data Scientist Joël Kuiper, and VP/Head of Search and ML Technology Arturo Devesa.

Name

Doctor Evidence

Legal name

Doctor Evidence, LLC

Website

https://drevidence.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

Dr.Evidence is an AI-powered labeling and regulatory intelligence platform serving biopharma companies, aggregating 100+ million documents from global health authorities and applying 25+ proprietary AI models to accelerate drug labeling, regulatory submissions, and competitive analysis.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Intelligence

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Regulatory intelligence platform
• Pharma labeling software
• Clinical trial analytics
• Biopharma AI solutions
• Drug label research

Headquarters

HQ city

Santa Monica

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: Subscription-based access to the AI-powered regulatory intelligence platform. Customers access the platform via login and receive white-glove search optimization and ongoing support as part of the service. Enterprise pricing likely varies by organization size and usage scope.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Dr.Evidence provides an AI-powered pharmaceutical labeling and regulatory landscape intelligence SaaS platform that consolidates 100+ million authoritative documents — including 728,000+ drug labels from 11 health authorities, 1.1 million clinical trials, 70 million scientific literature citations, and 140,000 FDA/EMA approval packages — into a single unified workflow. The platform deploys 25+ proprietary AI models with generative AI, machine learning, and natural language processing to help biopharma companies accelerate time-to-insight from weeks to hours for labeling, regulatory, and competitive intelligence use cases.

Product overview

Dr.Evidence is an AI-powered labeling and regulatory landscape intelligence platform designed specifically for biopharma companies. The platform combines deep life sciences expertise with fit-for-purpose AI to help companies get their products to market and keep them there. The unified platform integrates four core product modules: Labels Intelligence (for drug label research and comparison), Trials Intelligence (for clinical trial landscape analysis), Literature Intelligence (for scientific literature insights with AI summarization), and Regulatory Documents Intelligence (for FDA/EMA document querying). These modules are built on 25+ proprietary AI models and connect to 100+ million documents from authoritative health authority sources worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Labels Intelligence
• Trials Intelligence Optimizes clinical and regulatory strategy with a snapshot of the trial landscape, sourced from WHO ICTRP and including ClinicalTrials.gov, covering 1.1 million clinical trials; built for biopharma regulatory and clinical development teams.
• Literature Intelligence Efficiently identifies critical insights from scientific literature and clinical trial content with Generative AI Summarization, covering 70 million scientific literature citations, 400,000 congresses, 31 million patents, and 500,000 NIH grants, plus 2.1 million articles from healthcare RSS feeds; built for biopharma regulatory, clinical, and scientific affairs teams.
• Regulatory Documents Intelligence Quickly finds specific information in massive FDA and EMA documents with Generative AI Chat, covering 140,000 FDA and EMA approval packages, 4,000 guidance documents, and 49,000 Orange and Purple Book data points; designed for biopharma regulatory affairs teams preparing submissions and competitive analyses.

Quantifiable outcome

• 6:1 ROI by eliminating manual work and automating monitoring
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Clarivate (Cortellis): Provides Cortellis regulatory intelligence, drug labels, clinical trials, and scientific literature analytics through a subscription platform serving pharma competitive intelligence and regulatory affairs. Closest direct competitor in pharma regulatory/landscape intelligence, with comparable scale of curated content and a larger enterprise footprint.
• Citeline (formerly Pharma Intelligence / Informa): Offers Trialtrove, Pharmaprojects, Sitetrove, and other intelligence databases for clinical trials, drug development pipelines, and trial site selection. Overlaps with Dr.Evidence on clinical trial and drug landscape intelligence for biopharma R&D and regulatory strategy.
• GlobalData Healthcare: Provides pharma intelligence covering drug pipelines, clinical trials, label tracking, deals, and regulatory landscapes through subscription platforms such as Drugs Database and Clinical Trial Database. Comparable to Dr.Evidence in curating global regulatory and clinical intelligence for biopharma.
• Elsevier PharmaPendium: Pharmacokinetic, efficacy, safety, and regulatory approval database for approved drugs, used by pharma regulatory affairs and safety teams. Comparable to Dr.Evidence in providing label and regulatory document intelligence, owned by RELX/Elsevier with broader publishing reach.

Broad incumbents

• IQVIA: Global leader in clinical research, real-world evidence, and life sciences data analytics with regulatory and safety services overlapping Dr.Evidence's scope. Far larger and broader; competes at the top of pharma's vendor stack with deeper clinical and commercial data assets.
• Veeva Systems: Public cloud software leader for life sciences with Veeva Vault Regulatory and Vault Quality applications that manage regulatory submissions, label content, and document workflows for global biopharma. Overlaps with Dr.Evidence in regulatory and labeling data intelligence, though Veeva is broader (CRM, clinical, quality).
• Certara: Public biosimulation and regulatory science company offering software and services for drug development, including regulatory writing, evidence generation, and label/biopharmaceutics informatics. Directly comparable to Dr.Evidence in serving regulatory and labeling teams with technology-enabled intelligence.
• PAREXEL (part of EQT/Goldman portfolio): Large CRO with dedicated regulatory affairs consulting and proprietary regulatory intelligence tools for global submissions and labeling. Overlaps with Dr.Evidence in serving regulatory decision-makers, though PAREXEL bundles services with technology rather than selling a standalone AI platform.

Regional players

• Evidera (PPD, part of Thermo Fisher): Real-world evidence, health economics, and market access consultancy serving pharma, with regulatory and outcomes evidence generation adjacent to Dr.Evidence's evidence-intelligence scope. Comparable in pharma customer base but service-led rather than subscription-software-led.

Emerging players

• BioSymmetrics: AI-driven biomedical data integration and analytics platform that aggregates clinical, omics, and real-world data for pharma and translational research. Overlaps with Dr.Evidence on AI for biomedical data intelligence but is more focused on translational/preclinical use cases than regulatory labeling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/DoctorEvidence

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doctor Evidence